!1 New UpdateClick here for latest updates
Tamil Nadu Assembly session will be convened at Kalaivanar Arangam in Chennai from September 14 to September 16. All MLAs are needed to get tested for coronavirus 24 hours before the commencement of the session
– Assembly Speaker P Dhanapal
Kangana Ranaut has tested negative for COVID-19: Dr Devender Sharma, Chief Medical Officer, Mandi District, Himachal Pradesh
Egypt registers 187 new COVID-19 cases
Egypt reported on Tuesday 187 new COVID-19 infections, bringing the national tally to 100,228, said the Egyptian Health Ministry. Meanwhile, 19 deaths were reported, raising the death toll to 5,560, the ministry’s spokesman Khaled Megahed said in a statement. He noted that with 878 patients cured and discharged from hospitals in the past 24 hours, the nationwide recoveries rose to 79,886.
Assam’s Covid tally on Tuesday
As many as 2,579 new COVID-19 cases were reported in Assam on Tuesday, taking the total number of cases to 1,30,823 in the state. The total number of cases includes 99,073 recoveries, 378 deaths, and 31,369 active cases, State Health Minister Himanta Biswa Sarma said.
Gurugram’s Covid cases
The rapid increase of the coronavirus cases in Gurugram continued as 258 new infections have been detected in the district, officials said. One more patient infected with coronavirus died on Tuesday in the city. A total of 140 persons in the district have lost their lives to the dreaded virus to date. There are a total of 1,760 active Covid cases. A total of 11,806 have been cured and discharged. On Tuesday, 159 have been discharged after recovery.
Mainland China reported two new COVID-19 cases on Sept. 8, down from 10 a day earlier, the country’s national health authority said on Wednesday. The National Health Commission said in a statement that both cases were imported infections involving travellers from overseas, marking the 24th straight day of no local infections.
AstraZeneca COVID-19 vaccine study paused after one illness
- Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company investigates whether a patient suffered a serious side effect or if the illness had nothing to do with the shot.
- In a statement issued Tuesday evening, the company said its “standard review process triggered a pause to vaccination to allow review of safety data.”
- AstraZeneca didn’t reveal any information about the possible side effect except to call it “a potentially unexplained illness.” The health news site STAT first reported the pause in testing, saying the possible side effect occurred in the United Kingdom.
- An AstraZeneca spokesperson confirmed the pause in vaccinations covers studies in the U.S. and other countries. Late last month, AstraZeneca began recruiting 30,000 people in the U.S. for its largest study of the vaccine. It also is testing the vaccine, developed by Oxford University, in thousands of people in Britain, and in smaller studies in Brazil and South Africa.
Mexico reports total of 642,860 coronavirus cases, 68,484 deaths
Chhattisgarh recorded 2,545 COVID-19 cases, 615 recoveries and 12 deaths yesterday, taking total cases to 50,114 including 22,792 recoveries, 407 deaths and 26,915 active cases
– State Health Department
Brazil registers over 127,000 Covid-19 deaths
Argentine provinces strain as coronavirus cases top 500,000